Sports Anchor and Multiple Myeloma Patient Rod Gilmore Joins Amgen’s Myeloma MVP™ Team
Posted: Oct 31, 2019
Sports Anchor and Multiple Myeloma Patient Rod Gilmore Joins Amgen’s Myeloma MVP™ Team image

Rod Gilmore stands with arms crossed

Having a treatment plan is essential for all myeloma patients, regardless of where you are at in your treatment journey. College football anchor Rod Gilmore, who was diagnosed with multiple myeloma in July 2016, knows how challenging a new diagnosis can be and is partnering with Amgen Oncology as part of this year’s Myeloma MVP team.

“When I was diagnosed with multiple myeloma, I felt overwhelmed,” said Gilmore. “Through conversations with my healthcare team, I quickly realized I needed a game plan to help manage this disease, and this has made all the difference in helping me and my family cope. I want other patients and their families to be able to create a personal plan that is right for them, which is why I’ve teamed up with Amgen Oncology on the Myeloma MVP program.”

Amgen is expanding its Myeloma MVPTM, a national initiative to help myeloma patients and their care teams create their Most Valuable Plan. In its second year, Myeloma MVP now includes an updated tool on MyelomaExplained.com to help patients communicate with their doctors and develop a personal strategy for managing their disease.

Rod joins baseball greats Dave Winfield and Don Baylor Jr. to share the message that patients need to walk into their doctor's offices prepared. Together, they are honoring the legacy of teammate, father and baseball star Don Baylor, who passed away from multiple myeloma in 2017.

“Don Baylor was one of my best friends. He was also a great coach and teammate who always had a strategy and recognized the value of working as a team to face challenges. He took that same approach off the field in dealing with his multiple myeloma,” said Winfield. “Don’s experience inspired me to work with Amgen Oncology to spread the word about the Myeloma MVP program.”

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of Myeloma Crowd by HealthTree and the HealthTree Foundation.

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Bristol Myers Squibb
Abbvie
Genentech
GSK
Janssen Oncology

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation for Multiple Myeloma (formerly know as Myeloma Crowd) is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811